Annual SG&A
$26.06 M
+$5.82 M+28.75%
31 December 2023
Summary:
RAPT Therapeutics annual selling, general & administrative expenses is currently $26.06 million, with the most recent change of +$5.82 million (+28.75%) on 31 December 2023. During the last 3 years, it has risen by +$13.29 million (+104.06%). RAPT annual SG&A is now at all-time high.RAPT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.45 M
-$242.00 K-3.62%
30 September 2024
Summary:
RAPT Therapeutics quarterly selling, general & administrative expenses is currently $6.45 million, with the most recent change of -$242.00 thousand (-3.62%) on 30 September 2024. Over the past year, it has dropped by -$449.00 thousand (-6.51%). RAPT quarterly SG&A is now -16.66% below its all-time high of $7.74 million, reached on 31 March 2024.RAPT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.10 B
-$107.49 M-5.38%
30 September 2024
Summary:
RAPT Therapeutics TTM selling, general & administrative expenses is currently -$2.10 billion, with the most recent change of -$107.49 million (-5.38%) on 30 September 2024. Over the past year, it has dropped by -$2.13 billion (-8658.61%). RAPT TTM SG&A is now -1668.81% below its all-time high of $27.81 million, reached on 31 March 2024.RAPT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPT Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.8% | -6.5% | -8658.6% |
| 3 y3 years | +104.1% | +70.8% | -10000.0% |
| 5 y5 years | +403.1% | +272.1% | -10000.0% |
RAPT Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +104.1% | -16.7% | +70.8% | -119.2% | at low |
| 5 y | 5 years | at high | +403.1% | -16.7% | +272.1% | -293.6% | at low |
| alltime | all time | at high | +601.9% | -16.7% | +510.0% | -1668.8% | at low |
RAPT Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.45 M(-3.6%) | $27.33 M(-1.6%) |
| June 2024 | - | $6.69 M(-13.5%) | $27.78 M(-0.1%) |
| Mar 2024 | - | $7.74 M(+19.9%) | $27.81 M(+6.7%) |
| Dec 2023 | $26.06 M(+28.8%) | $6.45 M(-6.4%) | $26.06 M(+6.0%) |
| Sept 2023 | - | $6.90 M(+2.6%) | $24.58 M(+8.0%) |
| June 2023 | - | $6.72 M(+12.3%) | $22.77 M(+6.0%) |
| Mar 2023 | - | $5.99 M(+20.3%) | $21.48 M(+6.1%) |
| Dec 2022 | $20.24 M(+26.2%) | $4.98 M(-2.0%) | $20.24 M(+2.5%) |
| Sept 2022 | - | $5.08 M(-6.6%) | $19.75 M(+7.1%) |
| June 2022 | - | $5.44 M(+14.5%) | $18.45 M(+10.0%) |
| Mar 2022 | - | $4.75 M(+5.7%) | $16.77 M(+4.6%) |
| Dec 2021 | $16.04 M | $4.49 M(+19.0%) | $16.04 M(+6.7%) |
| Sept 2021 | - | $3.77 M(+0.4%) | $15.03 M(+4.0%) |
| June 2021 | - | $3.76 M(-6.3%) | $14.45 M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $4.01 M(+15.2%) | $13.49 M(+5.7%) |
| Dec 2020 | $12.77 M(+46.5%) | $3.48 M(+8.9%) | $12.77 M(+7.2%) |
| Sept 2020 | - | $3.20 M(+14.1%) | $11.91 M(+14.0%) |
| June 2020 | - | $2.80 M(-14.8%) | $10.45 M(+1.1%) |
| Mar 2020 | - | $3.29 M(+25.3%) | $10.34 M(+18.5%) |
| Dec 2019 | $8.72 M(+68.3%) | $2.63 M(+51.5%) | $8.72 M(+18.1%) |
| Sept 2019 | - | $1.73 M(-35.6%) | $7.39 M(+5.3%) |
| June 2019 | - | $2.69 M(+60.8%) | $7.02 M(+21.1%) |
| Mar 2019 | - | $1.67 M(+29.7%) | $5.80 M(+11.9%) |
| Dec 2018 | $5.18 M(+39.5%) | $1.29 M(-5.4%) | $5.18 M(+33.2%) |
| Sept 2018 | - | $1.36 M(-7.1%) | $3.89 M(+54.0%) |
| June 2018 | - | $1.47 M(+38.9%) | $2.52 M(+138.9%) |
| Mar 2018 | - | $1.06 M | $1.06 M |
| Dec 2017 | $3.71 M | - | - |
FAQ
- What is RAPT Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for RAPT Therapeutics?
- What is RAPT Therapeutics annual SG&A year-on-year change?
- What is RAPT Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for RAPT Therapeutics?
- What is RAPT Therapeutics quarterly SG&A year-on-year change?
- What is RAPT Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for RAPT Therapeutics?
- What is RAPT Therapeutics TTM SG&A year-on-year change?
What is RAPT Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of RAPT is $26.06 M
What is the all time high annual SG&A for RAPT Therapeutics?
RAPT Therapeutics all-time high annual selling, general & administrative expenses is $26.06 M
What is RAPT Therapeutics annual SG&A year-on-year change?
Over the past year, RAPT annual selling, general & administrative expenses has changed by +$5.82 M (+28.75%)
What is RAPT Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of RAPT is $6.45 M
What is the all time high quarterly SG&A for RAPT Therapeutics?
RAPT Therapeutics all-time high quarterly selling, general & administrative expenses is $7.74 M
What is RAPT Therapeutics quarterly SG&A year-on-year change?
Over the past year, RAPT quarterly selling, general & administrative expenses has changed by -$449.00 K (-6.51%)
What is RAPT Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of RAPT is -$2.10 B
What is the all time high TTM SG&A for RAPT Therapeutics?
RAPT Therapeutics all-time high TTM selling, general & administrative expenses is $27.81 M
What is RAPT Therapeutics TTM SG&A year-on-year change?
Over the past year, RAPT TTM selling, general & administrative expenses has changed by -$2.13 B (-8658.61%)